VIVS · NASDAQ
VivoSim Labs (VIVS) Stock Price & Fundamentals
VivoSim Labs (VIVS) closed at $593.03 on Oct 9, 2026, down 0.08% from the previous close of $593.50.
Share price, past year
1Y +30.13%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $593.03 |
| Sep 30, 2026 | $606.52 |
| Aug 31, 2026 | $575.99 |
| Jul 31, 2026 | $618.87 |
| Jun 30, 2026 | $602.39 |
| May 29, 2026 | $603.80 |
| Apr 30, 2026 | $590.36 |
| Mar 31, 2026 | $566.01 |
| Feb 27, 2026 | $520.51 |
| Jan 30, 2026 | $496.44 |
| Dec 31, 2025 | $487.17 |
| Nov 28, 2025 | $484.87 |
| Oct 31, 2025 | $463.44 |
Key statistics
- Market cap
- $1.89B
- P/E (TTM)
- —
- EPS (TTM)
- −$4.46
- Revenue (TTM)
- $112.00K
- Net income (TTM)
- −$12.34M
- Shares outstanding
- 3.2M
- Dividend yield
- —
- 52-week range
- $451.63 – $635.43
VivoSim Labs's market cap is $1.89B, based on a share price of $593.03 and 3.2M shares outstanding as of Jun 30, 2026.
Financials
VivoSim Labs reported revenue of $131.00K for fiscal 2026, down 9.03% from fiscal 2025.
VivoSim Labs reported a net loss of $13.84M in fiscal 2026.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended Mar 31, 2026 | $131.00K | −9.0% | −$13.84M | −10,567.2% | −$5.35 | −$10.83M |
| FY2025ended Mar 31, 2025 | $144.00K | +32.1% | −$2.49M | −1,727.8% | −$1.70 | −$9.47M |
| FY2024ended Mar 31, 2024 | $109.00K | −70.5% | −$14.67M | −13,459.6% | −$19.25 | −$14.70M |
| FY2023ended Mar 31, 2023 | $370.00K | −75.3% | −$17.26M | −4,664.6% | −$23.77 | −$12.80M |
| FY2022ended Mar 31, 2022 | $1.50M | — | −$11.45M | −763.2% | −$15.85 | −$8.86M |
| FY2021ended Mar 31, 2021 | $0.00 | −100.0% | −$16.83M | — | −$29.29 | −$13.73M |
| FY2020ended Mar 31, 2020 | $2.20M | −29.0% | −$18.71M | −852.0% | −$33.61 | −$14.88M |
| FY2019ended Mar 31, 2019 | $3.09M | −32.9% | −$26.64M | −861.7% | −$2.76 | −$20.45M |
| FY2018ended Mar 31, 2018 | $4.60M | +8.8% | −$34.80M | −756.1% | −$3.84 | −$29.08M |
| FY2017ended Mar 31, 2017 | $4.23M | — | −$38.45M | −908.9% | −$4.68 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2027ended Jun 30, 2026 | $18.00K | −$1.34M | −$0.25 |
| Q4 FY2026ended Mar 31, 2026 | $40.00K | −$5.76M | −$2.20 |
| Q3 FY2026ended Dec 31, 2025 | $26.00K | −$2.69M | −$1.03 |
| Q2 FY2026ended Sep 30, 2025 | $28.00K | −$2.55M | −$0.98 |
| Q1 FY2026ended Jun 30, 2025 | $37.00K | −$2.84M | −$1.14 |
| Q4 FY2025ended Mar 31, 2025 | $51.00K | $6.85M | $5.00 |
| Q3 FY2025ended Dec 31, 2024 | $24.00K | −$3.45M | −$2.28 |
| Q2 FY2025ended Sep 30, 2024 | $30.00K | −$2.55M | −$1.68 |
Company profile
- Name
- VivoSim Labs, INC.
- Ticker
- VIVS
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 11555 Sorrento Valley Road, Suite 100, San Diego, CA 92121
- Incorporated in
- DE
- Fiscal year ends
- March
- SEC CIK
- 0001497253
Recent SEC filings
- Oct 6, 2026
- Aug 21, 2026
- Aug 12, 2026
- Aug 6, 2026
- Jul 30, 2026
- Jul 24, 2026
- Jul 17, 2026
- Jul 14, 2026
Frequently asked questions
What is VivoSim Labs's stock price?
VivoSim Labs (VIVS) closed at $593.03 on Oct 9, 2026, down 0.08% from the previous close of $593.50.
What is VivoSim Labs's market cap?
VivoSim Labs's market cap is $1.89B, based on a share price of $593.03 and 3.2M shares outstanding as of Jun 30, 2026.
How much revenue does VivoSim Labs make?
VivoSim Labs reported revenue of $131.00K for fiscal 2026, down 9.03% from fiscal 2025.
Does VivoSim Labs pay a dividend?
VivoSim Labs's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from VivoSim Labs, INC.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures